5H-Pyrrolo [2,3-b] pyrazine derivatives for kinase modulation, and indications therefor

Details for Australian Patent Application No. 2009257635 (hide)

Owner Plexxikon, Inc.

Inventors Bremer, Ryan; Ibrahim, Prabha N.

Agent Spruson & Ferguson

Pub. Number AU-A-2009257635

PCT Pub. Number WO2009/152083

Priority 61/060,430 10.06.08 US

Filing date 8 June 2009

Wipo publication date 17 December 2009

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

13 January 2011 PCT application entered the National Phase

  PCT publication WO2009/152083 Priority application(s): WO2009/152083

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009257644-Magnetic microplate assembly

2009257631-Melanocortin receptor-specific peptides for treatment of sexual dysfunction